103
Participants
Start Date
August 31, 2001
Primary Completion Date
July 31, 2005
Study Completion Date
October 31, 2014
Exemestane
25mg/day until progression disease
Anastrozole
1mg/day until progression disease
Onkologikoa, Donostia / San Sebastian
Hospital Donostia, Donostia / San Sebastian
Hospital Clínico Universitario San Carlos, Madrid
Instituto Valenciano de Oncología (IVO), Valencia
Germans Trias i Pujol, Badalona
Clínico Universitario A Coruña (CHUAC), A Coruña
H Comarcal de Barbastro, Barbastro
H Puerto de Sagunto, Sagunto
Puerta de Hierro, Madrid
Ruber Internacional, Madrid
H Sant Camil, Tarragona
Clínico Lozano Blesa, Zaragoza
H Universitario Miguel Servet, Zaragoza
Collaborators (1)
Pfizer
INDUSTRY
Spanish Breast Cancer Research Group
OTHER